fda compounding semaglutide warning letters october 2025 Compounded "semaglutide" is not FDA-approved Societies take stand against off-brand

The risk-benefit calculus shifts at higher doses

Through NovoCare's direct cash-pay program, Wegovy injection costs $199 to $349 per month depending on dose

Home reconstitution of unlicensed injectable peptides carries serious risks including microbial contamination, severe dosing errors, chemical degradation, and injection site complications such as abscess or infection

In the case that one has at least one medical condition resulting from obesity, like hypertension, diabetes, sleep apnea, etc., this drug could be used starting at a BMI of 27, which would be equivalent to a lower weight compared to healthier individuals